Brief report
Noninfectious aortitis: Experience with tocilizumab in a regional hospital
Aortitis no infecciosa: experiencia con tocilizumab en un hospital comarcal
Read
4465
Timeswas read the article
1804
Total PDF
2661
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 7 | 0 | 37 | 37 |
| 2025 6 | 1 | 20 | 21 |
| 2025 5 | 85 | 37 | 122 |
| 2025 4 | 66 | 20 | 86 |
| 2025 3 | 73 | 29 | 102 |
| 2025 2 | 43 | 32 | 75 |
| 2025 1 | 76 | 38 | 114 |
| 2024 12 | 31 | 29 | 60 |
| 2024 11 | 44 | 53 | 97 |
| 2024 10 | 39 | 25 | 64 |
| 2024 9 | 35 | 18 | 53 |
| 2024 8 | 42 | 36 | 78 |
| 2024 7 | 34 | 31 | 65 |
| 2024 6 | 35 | 18 | 53 |
| 2024 5 | 49 | 25 | 74 |
| 2024 4 | 36 | 26 | 62 |
| 2024 3 | 35 | 28 | 63 |
| 2024 2 | 33 | 21 | 54 |
| 2024 1 | 29 | 23 | 52 |
| 2023 12 | 26 | 23 | 49 |
| 2023 11 | 33 | 26 | 59 |
| 2023 10 | 27 | 27 | 54 |
| 2023 9 | 130 | 36 | 166 |
| 2023 8 | 29 | 16 | 45 |
| 2023 7 | 21 | 20 | 41 |
| 2023 6 | 28 | 23 | 51 |
| 2023 5 | 31 | 15 | 46 |
| 2023 4 | 21 | 8 | 29 |
| 2023 3 | 49 | 17 | 66 |
| 2023 2 | 54 | 23 | 77 |
| 2023 1 | 25 | 23 | 48 |
| 2022 12 | 56 | 28 | 84 |
| 2022 11 | 49 | 26 | 75 |
| 2022 10 | 67 | 35 | 102 |
| 2022 9 | 34 | 20 | 54 |
| 2022 8 | 31 | 37 | 68 |
| 2022 7 | 32 | 41 | 73 |
| 2022 6 | 42 | 31 | 73 |
| 2022 5 | 44 | 37 | 81 |
| 2022 4 | 72 | 30 | 102 |
| 2022 3 | 42 | 40 | 82 |
| 2022 2 | 37 | 33 | 70 |
| 2022 1 | 47 | 30 | 77 |
| 2021 12 | 47 | 43 | 90 |
| 2021 11 | 49 | 40 | 89 |
| 2021 10 | 51 | 44 | 95 |
| 2021 9 | 28 | 37 | 65 |
| 2021 8 | 23 | 36 | 59 |
| 2021 7 | 25 | 26 | 51 |
| 2021 6 | 27 | 23 | 50 |
| 2021 5 | 30 | 48 | 78 |
| 2021 4 | 83 | 93 | 176 |
| 2021 3 | 60 | 42 | 102 |
| 2021 2 | 40 | 19 | 59 |
| 2021 1 | 55 | 23 | 78 |
| 2020 12 | 30 | 17 | 47 |
| 2020 11 | 28 | 18 | 46 |
| 2020 10 | 29 | 14 | 43 |
| 2020 9 | 76 | 27 | 103 |
| 2020 8 | 76 | 22 | 98 |
| 2020 7 | 43 | 19 | 62 |
| 2020 6 | 18 | 3 | 21 |
| 2020 5 | 30 | 19 | 49 |
Show all
